本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

10.04
-0.2500-2.43%
成交量:4.69萬
成交額:47.62萬
市值:8.75億
市盈率:-4.72
高:10.34
開:10.29
低:10.03
收:10.29
52周最高:36.26
52周最低:6.65
股本:8,715.70萬
流通股本:7,188.81萬
量比:0.82
換手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
淨資產收益率:-52.74%
總資產收益率:-31.82%
市淨率:2.03
市盈率(LYR):-5.37

資料載入中...

2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/22

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/16

重要事件披露

8-K - Current report
2022/11/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/23

重要事件披露

8-K - Current report